UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Biomimetic, folic acid-modified mesoporous silica nanoparticles with “stealth” and “homing” capabilities for tumor therapy Journal article
Hu, Xianlong, Xiong, Wei, Liu, Xingkang, Wang, Jianwei, Wang, Shuai, Chen, Qiling, Gao, Keqin, Li, Chenyang, Li, Ying. Biomimetic, folic acid-modified mesoporous silica nanoparticles with “stealth” and “homing” capabilities for tumor therapy[J]. Materials and Design, 2024, 241, 112899.
Authors:  Hu, Xianlong;  Xiong, Wei;  Liu, Xingkang;  Wang, Jianwei;  Wang, Shuai; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:7.6/8.4 | Submit date:2024/05/16
Biomimetic  Immune Escape  Macrophage Membrane  Mesoporous Silica Nanoparticles  Tumor Targeting  
The “whole ingredients extract” of Astragali Radix improves the symptoms of dextran sulfate sodium-induced ulcerative colitis in mice through systemic immunomodulation Journal article
Linghu, Ke Gang, Ma, Qiushuo, Xiong, Shi Hang, Zhao, Mingming, Chen, Qiling, Xu, Wen, Chen, Meiwan, Zhang, Jian Ye, Hu, Yuanjia, Xu, Wei, Yu, Hua. The “whole ingredients extract” of Astragali Radix improves the symptoms of dextran sulfate sodium-induced ulcerative colitis in mice through systemic immunomodulation[J]. Chinese Medicine (United Kingdom), 2022, 17(1), 109.
Authors:  Linghu, Ke Gang;  Ma, Qiushuo;  Xiong, Shi Hang;  Zhao, Mingming;  Chen, Qiling; et al.
Favorite | TC[WOS]:4 TC[Scopus]:5  IF:5.3/5.5 | Submit date:2023/01/30
Astragali Radix  Whole Ingredients Extract  Immunomodulation  Ulcerative Colitis  
Anti-inflammatory/anti-oxidant properties and the UPLC-QTOF/MS-based metabolomics discrimination of three yellow camellia species Journal article
Zhao, Mingming, Linghu, Ke-Gang, Xiao, Linxuan, Hua, Tianyi, Zhao, Guanding, Chen, Qiling, Xiong, Shihang, Shen, Liyu, Yu, Jinyu, Hou, Xiaotao, Hao, Erwei, Du, Zhengcai, Deng, Jiagang, Bai, Gang, Chen, Xiaojia, Li, Ling, Li, Peng, Yu, Hua. Anti-inflammatory/anti-oxidant properties and the UPLC-QTOF/MS-based metabolomics discrimination of three yellow camellia species[J]. Food Research International, 2022, 160, 111628.
Authors:  Zhao, Mingming;  Linghu, Ke-Gang;  Xiao, Linxuan;  Hua, Tianyi;  Zhao, Guanding; et al.
Favorite | TC[WOS]:14 TC[Scopus]:14  IF:7.0/7.4 | Submit date:2022/08/18
Yellow Camellias  Discrimination  Metabolomics  Fingerprint  Anti -inflammation  Anti -oxidant  
Comprehensive comparison on the anti-inflammation and GC-MS-based metabolomics discrimination between Bupleuri chinense DC. and B. scorzonerifolium Willd Journal article
Zhao, Mingming, Xiao, Linxuan, Linghu, Ke Gang, Zhao, Guanding, Chen, Qiling, Shen, Liyu, Dar, Parsa, Chen, Meiwan, Hu, Yuan, Zhang, Jinming, Yu, Hua. Comprehensive comparison on the anti-inflammation and GC-MS-based metabolomics discrimination between Bupleuri chinense DC. and B. scorzonerifolium Willd[J]. Frontiers in Pharmacology, 2022, 13, 1005011.
Authors:  Zhao, Mingming;  Xiao, Linxuan;  Linghu, Ke Gang;  Zhao, Guanding;  Chen, Qiling; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:4.4/5.0 | Submit date:2023/01/30
Anti-infammation  Bupleuri Radix  Gc-ms  Metabolomics  Species Discrimination  
Structural characterization and discrimination of three yellow camellia species with UPLC-QTOF-MS/MS based metabolomics and their anti-inflammatory/anti-oxidant activities on RAW264.7 cells Conference paper
Zhao, Mingming, Kinghu, Kegang, Zhao, Guanding, Xiong, Shihang, Ma, Qiushuo, Chen, Qiling, Hua, Tianyi, Yu, Jinyu, Shen, Liyu, Hou, Xiaotao, Hao, Erwei, Du, Zhengcai, Deng, Jiagang, Chen, Xiaojia, Li, Peng, Yu, Hua. Structural characterization and discrimination of three yellow camellia species with UPLC-QTOF-MS/MS based metabolomics and their anti-inflammatory/anti-oxidant activities on RAW264.7 cells[C], Xi'an:The 4th International Symposium on Phytochemicals in Medicine and Food, 2020.
Authors:  Zhao, Mingming;  Kinghu, Kegang;  Zhao, Guanding;  Xiong, Shihang;  Ma, Qiushuo; et al.
Favorite |  | Submit date:2022/08/02
Yellow Camellia Species  Metabolomics  Anti-inflammation  Anti-oxidant  
SRC-3 is required for CAR-regulated hepatocyte proliferation and drug metabolism Journal article
Tenghui Chen, Qiang Chen, Yixiang Xu, Qiling Zhou, Jingwei Zhu, Hao Zhang, Qiao Wu, Jianming Xu, Chundong Yu. SRC-3 is required for CAR-regulated hepatocyte proliferation and drug metabolism[J]. JOURNAL OF HEPATOLOGY, 2012, 56(1), 210-217.
Authors:  Tenghui Chen;  Qiang Chen;  Yixiang Xu;  Qiling Zhou;  Jingwei Zhu; et al.
Favorite | TC[WOS]:16 TC[Scopus]:20  IF:26.8/28.0 | Submit date:2019/01/22
Src-3  Car  Hepatocyte Proliferation  Drug Metabolism